Are infantile periarteritis nodosa with coronary artery involvement and fatal mucocutaneous lymph node syndrome the same? Comparison of 20 patients from North America with patients... von Landing, B H, Larson, E J

Volltext

Overwhelming neonatal infection with ECHO 19 virus von Philip, Alistair G.S., Larson, Eunice J.

Volltext

Association of hemolytic anemia and early-onset pulmonary emphysema in three siblings von Anderson, Carol E., Finklestein, Jerry Z., Nussbaum, Eliezer, Larson, Eunice J., Halpern, Roy, Uitto, Jouni, Tanaka, Kouichi R.

Volltext

THE DIAGNOSIS OF FETAL HYDROCEPHALUS BEFORE VIABILITY von FREEMAN, ROGER K., MCQUOWN, DENNIS S., SECRIST, LEE J., LARSON, EUNICE J.

Volltext

Chromosome abnormalities in a case of pulmonary blastoma von Tom, Winston W., Finklestein, Jerry V., Larson, Eunice J., Willis, Jane, Sandlin, Constance J.

Volltext

Follow-up of patients with R/R FLT3-mutation–positive AML treated with gilteritinib in the phase 3 ADMIRAL trial von Perl, Alexander E., Larson, Richard A., Podoltsev, Nikolai A., Strickland, Stephen, Wang, Eunice S., Atallah, Ehab, Schiller, Gary J., Martinelli, Giovanni, Neubauer, Andreas, Sierra, Jorge, Montesinos, Pau, Récher, Christian, Yoon, Sung-Soo, Hosono, Naoko, Onozawa, Masahiro, Chiba, Shigeru, Kim, Hee-Je, Hasabou, Nahla, Lu, Qiaoyang, Tiu, Ramon, Levis, Mark J.

Volltext

Bortezomib Added to Daunorubicin and Cytarabine During Induction Therapy and to Intermediate-Dose Cytarabine for Consolidation in Patients With Previously Untreated Acute Myeloid L... von ATTAR, Eyal C, JOHNSON, Jeffrey L, BLUM, William, STONE, Richard M, MARCUCCI, Guido, BLOOMFIELD, Clara D, MOSER, Barry, LARSON, Richard A, AMREIN, Philip C, LOZANSKI, Gerard, WADLEIGH, Martha, DEANGELO, Daniel J, KOLITZ, Jonathan E, POWELL, Bayard L, VOORHEES, Peter, WANG, Eunice S

Volltext

Tolerability and Efficacy of the Anticluster of Differentiation 47 Antibody Magrolimab Combined With Azacitidine in Patients With Previously Untreated AML: Phase Ib Results von Daver, Naval G, Vyas, Paresh, Kambhampati, Suman, Al Malki, Monzr M, Larson, Richard A, Asch, Adam S, Mannis, Gabriel, Chai-Ho, Wanxing, Tanaka, Tiffany N, Bradley, Terrence J, Jeyakumar, Deepa, Wang, Eunice S, Sweet, Kendra, Kantarjian, Hagop M, Garcia-Manero, Guillermo, Komrokji, Rami, Xing, Guan, Ramsingh, Giridharan, Renard, Camille, Zeidner, Joshua F, Sallman, David A

Volltext

Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503) von Blum, W, Sanford, B L, Klisovic, R, DeAngelo, D J, Uy, G, Powell, B L, Stock, W, Baer, M R, Kolitz, J E, Wang, E S, Hoke, E, Mrózek, K, Kohlschmidt, J, Bloomfield, C D, Geyer, S, Marcucci, G, Stone, R M, Larson, R A

Volltext

Neurodevelopmental outcome of preterm infants enrolled in myo-inositol randomized controlled trial von Adams-Chapman, Ira, Watterberg, Kristi L., Nolen, Tracy L., Hirsch, Shawn, Cole, Carol A., Cotten, C. Michael, Oh, William, Poindexter, Brenda B., Zaterka-Baxter, Kristin M., Das, Abhik, Lacy, Conra Backstrom, Scorsone, Ann Marie, Duncan, Andrea F., DeMauro, Sara B., Goldstein, Ricki F., Colaizy, Tarah T., Wilson-Costello, Deanne E., Purdy, Isabell B., Hintz, Susan R., Heyne, Roy J., Myers, Gary J., Fuller, Janell, Merhar, Stephanie, Harmon, Heidi M., Peralta-Carcelen, Myriam, Kilbride, Howard W., Maitre, Nathalie L., Vohr, Betty R., Natarajan, Girija, Mintz-Hittner, Helen, Quinn, Graham E., Wallace, David K., Olson, Richard J., Orge, Faruk H., Tsui, Irena, Gaynon, Michael, Hutchinson, Amy K., He, Yu-Guang, Winter, Timothy W., Yang, Michael B., Haider, Kathryn M., Cogen, Martin S., Hug, Denise, Bremer, Don L., Donahue, John P., Lucas, William R., Phelps, Dale L., Higgins, Rosemary D.

Volltext

Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory Acute Myelogenous Leukemia Who Underwent Transplantation in the Phase 3 ADMIRAL Trial of Gilteritinib versus Salvage Che... von Perl, Alexander E., Larson, Richard A., Podoltsev, Nikolai A., Strickland, Stephen, Wang, Eunice S., Atallah, Ehab, Schiller, Gary J., Martinelli, Giovanni, Neubauer, Andreas, Sierra, Jorge, Montesinos, Pau, Recher, Christian, Yoon, Sung-Soo, Maeda, Yoshinobu, Hosono, Naoko, Onozawa, Masahiro, Kato, Takayasu, Kim, Hee-Je, Hasabou, Nahla, Nuthethi, Rishita, Tiu, Ramon, Levis, Mark J.

Volltext

Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance) von Walker, Alison R., Marcucci, Guido, Yin, Jun, Blum, William, Stock, Wendy, Kohlschmidt, Jessica, Mrózek, Krzysztof, Carroll, Andrew J., Eisfeld, Ann-Kathrin, Wang, Eunice S., Jacobson, Sawyer, Kolitz, Jonathan E., Thakuri, Mohan, Sutamtewagul, Grerk, Vij, Ravi, Stuart, Robert K., Byrd, John C., Bloomfield, Clara D., Stone, Richard M., Larson, Richard A.

Volltext

Imlunestrant, an Oral Selective Estrogen Receptor Degrader, as Monotherapy and in Combination With Targeted Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Rec... von Jhaveri, Komal L, Lim, Elgene, Jeselsohn, Rinath, Ma, Cynthia X, Hamilton, Erika P, Osborne, Cynthia, Bhave, Manali, Kaufman, Peter A, Beck, J. Thaddeus, Manso Sanchez, Luis, Parajuli, Ritesh, Wang, Hwei-Chung, Tao, Jessica J, Im, Seock-Ah, Harnden, Kathleen, Yonemori, Kan, Dhakal, Ajay, Neven, Patrick, Aftimos, Philippe, Pierga, Jean-Yves, Lu, Yen-Shen, Larson, Timothy, Jerez, Yolanda, Sideras, Kostandinos, Sohn, Joohyuk, Kim, Sung-Bae, Saura, Cristina, Bardia, Aditya, Sammons, Sarah L, Bacchion, Francesca, Li, Yujia, Yuen, Eunice, Estrem, Shawn T, Rodrik-Outmezguine, Vanessa, Nguyen, Bastien, Ismail-Khan, Roohi, Smyth, Lillian, Beeram, Muralidhar

Volltext

Randomized trial of 10 days of decitabine ± bortezomib in untreated older patients with AML: CALGB 11002 (Alliance) von Roboz, Gail J., Mandrekar, Sumithra J., Desai, Pinkal, Laumann, Kristina, Walker, Alison R., Wang, Eunice S., Kolitz, Jonathan E., Powell, Bayard L., Attar, Eyal C., Stock, Wendy, Bloomfield, Clara D., Kohlschmidt, Jessica, Mrózek, Krzysztof, Hassane, Duane C., Garraway, Levi, Jané-Valbuena, Judit, Baltay, Michele, Tracy, Adam, Marcucci, Guido, Stone, Richard M., Larson, Richard A.

Volltext

Tolerability and efficacy of the first-in-class anti-CD47 antibody magrolimab combined with azacitidine in frontline TP53m AML patients: Phase 1b results von Daver, Naval Guastad, Vyas, Paresh, Kambhampati, Suman, Al Malki, Monzr M., Larson, Richard A., Asch, Adam Steven, Mannis, Gabriel N., Chai-Ho, Wanxing, Tanaka, Tiffany N., Bradley, Terrence J., Jeyakumar, Deepa, Wang, Eunice S., Xing, Guan, Chao, Mark, Ramsingh, Giridharan, Renard, Camille, Lal, Indu, Zeidner, Joshua F., Sallman, David Andrew

Volltext

Follow-up of patients with FLT3- mutated R/R AML in the phase 3 ADMIRAL trial von Perl, Alexander E., Larson, Richard A., Podoltsev, Nikolai Alexandrovich, Strickland, Stephen, Wang, Eunice S., Schiller, Gary J., Martinelli, Giovanni, Neubauer, Andreas, Sierra, Jorge, Montesinos, Pau, Recher, Christian, Yoon, Sung-Soo, Hosono, Naoko, Onozawa, Masahiro, Chiba, Shigeru, Kim, Hee-Je, Hasabou, Nahla, Lu, Qiaoyang, Tiu, Ramon Velasquez, Levis, Mark J.

Volltext

Deep molecular response to gilteritinib to improve survival in FLT3 mutation-positive relapsed/refractory acute myeloid leukemia von Altman, Jessica K., Perl, Alexander E., Cortes, Jorge E., Smith, Catherine Choy, Litzow, Mark Robert, Hill, Jason E, Larson, Richard A., Liu, Charles, Ritchie, Ellen K., Strickland, Stephen Anthony, Wang, Eunice S., Neubauer, Andreas, Martinelli, Giovanni, Bahceci, Erkut, Levis, Mark J.

Volltext

Abstract PD13-12: PD13-12 Imlunestrant, an oral selective estrogen receptor degrader, in combination with abemaciclib with or without an aromatase inhibitor, in estrogen receptor-p... von Jhaveri, Komal, Wang, Hwei-Chung, Ma, Cynthia, Lim, Elgene, Tao, Jessica J., Manso, Luis, Pierga, Jean-Yves, Parajuli, Ritesh, Gilarranz, Yolanda Jerez, Lu, Yen-Shen, Beeram, Muralidhar, Larson, Tim, Dhakal, Ajay, Ismail-Khan, Roohi, Karacsonyi, Claudia, Cao, Shanshan, Osborne, Cynthia, Estrem, Shawn T., Nguyen, Bastien, Li, Yujia, Yuen, Eunice

Volltext

Final Results of the Chrysalis Trial: A First-in-Human Phase 1/2 Dose-Escalation, Dose-Expansion Study of Gilteritinib (ASP2215) in Patients with Relapsed/Refractory Acute Myeloid... von Perl, Alexander E., Altman, Jessica K., Cortes, Jorge E., Smith, Catherine C., Litzow, Mark, Baer, Maria R., Claxton, David F., Erba, Harry P., Gill, Stanley C., Goldberg, Stuart L., Jurcic, Joseph G., Larson, Richard A., Liu, Charles, Ritchie, Ellen K., Schiller, Gary J., Spira, Alexander I., Strickland, Stephen A., Tibes, Raoul, Ustun, Celalettin, Wang, Eunice S., Stuart, Robert K., Röllig, Christoph, Neubauer, Andreas, Martinelli, Giovanni, Bahceci, Erkut, Levis, Mark J.

Volltext

Results of a first-in-human, phase I/II trial of ASP2215, a selective, potent inhibitor of FLT3/Axl in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) von Levis, Mark J., Perl, Alexander E., Altman, Jessica K., Cortes, Jorge E., Ritchie, Ellen K., Larson, Richard A., Smith, Catherine Choy, Wang, Eunice S., Strickland, Stephen Anthony, Baer, Maria R., Litzow, Mark Robert, Claxton, David, Schiller, Gary J., Ustun, Celalettin, Liu, Charles, Gill, Stan, Sargent, Briana, Bahceci, Erkut

Volltext